Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies. - Wikidata - wikimedia - TriplyDB

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

http://www.wikidata.org/entity/Q37394278

about

A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours.Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of therapeutic biologics.A novel fully human antitumor immunoRNase resistant to the RNase inhibitor Human ribonuclease with a pendant poly(ethylene glycol) inhibits tumor growth in mice.Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.Antibody-enzyme fusion proteins for cancer therapy.Effects of a human compact anti-ErbB2 antibody on gastric cancer.Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis

P2860

Q35034584-F04B0F42-EBCD-4F53-9E8D-C994BE83C0EB Q35541200-F657B4C0-A324-4AAB-A652-F31F9896492F Q36331497-37CA3679-225B-4BE5-8094-EA910B6D87B7 Q36610794-CF9C4242-7727-45A7-9EAF-4EB88C5EAEAB Q37060935-492C9377-7AF0-4972-A117-B4FEA4F8D805 Q37586081-ADF73509-BCE6-4B82-B7F2-4836086BC1E8 Q37842324-9A9609B0-274C-4B22-8CF4-5102B48AD5D1 Q39185414-6035D43C-AF56-4F8D-8255-CBCA7FBF06CF Q56974525-BE6814BC-2B18-4FBD-82AD-26211230CE2C

P2860

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

http://www.wikidata.org/entity/Q37394278

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@en

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@nl

type

label

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@en

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@nl

prefLabel

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@en

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@nl

P1433

Q37394278-CF6887B2-2132-416F-9EB7-EA7B37C9CC80

P1476

Q37394278-7A295953-B91A-4DE0-8253-C0FFAE424EDD

P2093

Q37394278-85C52344-C315-4B8B-BD8D-5999B702B7BE

Q37394278-9763D8AB-08DF-43DD-BFBE-CFBE19F41F87

P2860

Q37394278-0204A67B-AF1C-4FCA-82CB-DED3E07C1677

Q37394278-025693CE-30C6-40B4-B50C-9BEA8DE9640A

Q37394278-092FB202-9288-43D3-9F58-95DCE5D6F454

Q37394278-09E9A5BC-317E-43B3-970C-C2D5028C1299

Q37394278-0C34A839-6309-46B2-A9CB-2DA1E464CA80

Q37394278-158F1E14-5D28-4989-B129-52A44F67F724

Q37394278-16074F11-15B6-496F-A72D-F28BE20ADB7B

Q37394278-1861183B-ECB0-4803-9A2B-E35A48346B60

Q37394278-1AAFBBF4-926E-4FED-A8C5-EC188D330E7D

Q37394278-26CF5917-7815-4D1B-AC3E-633BDAEE0288

P304

Q37394278-C9C6D509-2A2C-410E-B0AB-2EC4968469E7

P31

Q37394278-6042CA88-B7FF-49D0-9B23-CBCA88FC6D1A

P356

Q37394278-E3041802-C549-4645-8B7C-58357C28A058

P407

Q37394278-954376CB-7BDC-4989-888B-C206839CB0C0

P433

Q37394278-04BEFE81-1F24-4926-B2B1-4801C7D12311

P478

Q37394278-B3288A1F-E6EE-43F2-84B5-C826C2ABE85E

P577

Q37394278-D24F1866-3EF6-4E36-90AD-DAD87A873B36

P5875

Q37394278-3E13E5FD-5164-4650-A916-A9F2B3746E31

P698

Q37394278-6ABFFD8E-9125-4201-B53B-8D0AA1D83693

P921

Q37394278-95F3B8B9-46F6-4A91-9885-66D7AEEB8D5E

P356

J.1742-4658.2009.06896.X

P1433

P1476

Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.

@en

P2093

Claudia De Lorenzo

http://www.w3.org/2001/XMLSchema#string

Giuseppe D'Alessio

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Engineered antibodies

Improving the efficacy of antibody-based cancer therapies

Ribonuclease inhibitor: structure and function

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Expression of single-chain Fv-Fc fusions in Pichia pastoris.

Natural and designer binding sites made by phage display technology.

Internalizing antibodies and targeted cancer therapy: direct selection from phage display libraries.

Selection of tumor-specific internalizing human antibodies from phage libraries.

Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma.

P304

1527-1535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-4658.2009.06896.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24018550

http://www.w3.org/2001/XMLSchema#string

P698

19220462

http://www.w3.org/2001/XMLSchema#string

P921